Pliant Therapeutics is a company focused on discovering, developing, and commercializing treatments for fibrotic diseases. By harnessing the therapeutic potential of integrin biology and TGF-β modulation, the company aims to prevent or reverse fibrosis to address the needs of patients. It also builds a patient registry for certain areas of fibrotic disease to both increase understanding of natural disease progression, and fuel biomarker discovery.